RecruitingNot ApplicableNCT07269366

Surgical Versus Percutaneous Revascularization in Patients With Reduced Left Ventricular Function (STICH 3.0-NL)

Surgical Versus Percutaneous Revascularization in Patients With Reduced Left Ventricular Function

Sponsor

University Medical Center Groningen

Enrollment

358 participants

Start Date

May 1, 2026

Study Type

INTERVENTIONAL

Conditions

Heart Failure Coronary Artery Disease Coronary Artery Disease (CAD)Revascularization CABG Multivessel Coronary Artery Disease PCI CABG in Low EF

Summary

This randomized multicenter trial compares coronary artery bypass grafting (CABG) with percutaneous coronary intervention (PCI) in 358 patients with ischemic left ventricular dysfunction and multivessel coronary disease. The study evaluates differences in survival, major cardiovascular events, and quality of life over 4 years, and contributes to the international STICH 3.0 collaboration assessing long-term outcomes.

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a procedure called CABG and a procedure called PCI for people with cabg, cabg in low ef, and other related conditions. The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.